Gianfabio Giorgioni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

Pharmaceuticals (Basel, Switzerland)

Nutrients

University of Camerino

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Camerino Feb 17 1990

Italy

Assistant Professor :: School of Pharmacy

Publications

Federica Matteucci, Marta Ferrati, Eleonora Spinozzi, Alessia Piergentili, Fabio Del Bello, Gianfabio Giorgioni, Leonardo Sorci, Riccardo Petrelli, Loredana Cappellacci
Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Maria Beatrice Morelli, Miriam Caviglia, Carlo Santini, Jo' Del Gobbo, Laura Zeppa, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Chiara Battocchio, Federica Bertelà, Simone Amatori, Carlo Meneghini, Giovanna Iucci, Andrea Bearzotti, Alessandro Dolmella, Michele Di Palma, Maura Pellei
Copper-Based Complexes with Adamantane Ring-Conjugated bis (3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma. Journal of medicinal chemistry 67 (11) (2024)
Federica Matteucci, Marta Ferrati, Eleonora Spinozzi, Alessia Piergentili, Fabio Del Bello, Gianfabio Giorgioni, Leonardo Sorci, Riccardo Petrelli, Loredana Cappellacci
Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Maria Beatrice Morelli, Miriam Caviglia, Carlo Santini, Jo' Del Gobbo, Laura Zeppa, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Chiara Battocchio, Federica Bertelà, Simone Amatori, Carlo Meneghini, Giovanna Iucci, Andrea Bearzotti, Alessandro Dolmella, Michele Di Palma, Maura Pellei
Copper-Based Complexes with Adamantane Ring-Conjugated bis (3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma. Journal of medicinal chemistry (2024)
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Elizabeth Saab, Luca Botticelli, Carlo Cifani, Emanuela Micioni Di Bonaventura, Maria Vittoria Micioni Di Bonaventura, Wilma Quaglia
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders. Medicinal research reviews (2023)
Cecilia Baldassarri, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Stefano Fontana, Valerio Mammoli, Gabriele Minazzato, Elisa Marangoni, Massimiliano Gasparrini, Leonardo Sorci, Nadia Raffaelli, Loredana Cappellacci, Riccardo Petrelli, Fabio Del Bello
Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Gianfabio Giorgioni, Fabio Del Bello, Wilma Quaglia, Luca Botticelli, Carlo Cifani, Emanuela Micioni Di Bonaventura, Maria Vittoria Micioni Di Bonaventura, Alessandro Piergentili
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor. Journal of medicinal chemistry 65 (4) (2022)
Pegi Pavletić, Ana Semeano, Hideaki Yano, Alessandro Bonifazi, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Maria Giovanna Sabbieti, Dimitrios Agas, Giorgio Santoni, Roberto Pallini, Lucia Ricci-Vitiani, Emanuela Sabato, Vistoli Giulio, Fabio Del Bello
Highly Potent and Selective Dopamine D 4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma. Journal of medicinal chemistry 65 (18) (2022)
Fabio Del Bello, Maura Pellei, Luca Bagnarelli, Carlo Santini, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Chiara Battocchio, Giovanna Iucci, Irene Schiesaro, Carlo Meneghini, Andrea Bearzotti, Nitya Ramanan, Michele De Franco, Paolo Sgarbossa, Cristina Marzano, Valentina Gandin
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects. Inorganic chemistry 61 (12) (2022)
Alessandro Bonifazi, Amy Hauck Newman, Thomas M Keck, Silvia Gervasoni, Vistoli Giulio, Fabio Del Bello, Gianfabio Giorgioni, Pegi Pavletić, Wilma Quaglia, Alessandro Piergentili
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders. ACS chemical neuroscience 12 (19) (2021)
Maura Pellei, Luca Bagnarelli, Lorenzo Luciani, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Michele De Franco, Valentina Gandin, Cristina Marzano, Carlo Santini
Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist. International journal of molecular sciences 21 (7) (2020)
Carlo Cifani, Emanuela Micioni Di Bonaventura, Luca Botticelli, Fabio Del Bello, Gianfabio Giorgioni, Pegi Pavletić, Alessandro Piergentili, Wilma Quaglia, Alessandro Bonifazi, Dirk Schepmann, Bernhard Wünsch, Vistoli Giulio, Maria Vittoria Micioni Di Bonaventura
Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats. ACS chemical neuroscience 11 (19) (2020)
Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Alessandro Piergentili, Maria Giovanna Sabbieti, Dimitrios Agas, Marzia Dell'Aera, Rosanna Matucci, Marcin Górecki, Gennaro Pescitelli, Vistoli Giulio, Wilma Quaglia
Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus. Journal of medicinal chemistry 63 (11) (2020)
Luca Botticelli, Emanuela Micioni Di Bonaventura, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Adele Romano, Wilma Quaglia, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura
Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors. Nutrients 12 (8) (2020)
Fabio Del Bello, Maria Vittoria Micioni Di Bonaventura, Alessandro Bonifazi, Bernhard Wünsch, Dirk Schepmann, JoLynn B Giancola, Emanuela Micioni Di Bonaventura, Vistoli Giulio, Gianfabio Giorgioni, Wilma Quaglia, Alessandro Piergentili, Carlo Cifani
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane. ACS chemical neuroscience 10 (8) (2019)
Diego Romano Perinelli, Dezemona Petrelli, Luca Agostino Vitali, Giulia Bonacucina, Marco Cespi, Driton Vllasaliu, Gianfabio Giorgioni, Giovanni Filippo Palmieri
Quaternary Ammonium Leucine-Based Surfactants: The Effect of a Benzyl Group on Physicochemical Properties and Antimicrobial Activity. Pharmaceutics 11 (6) (2019)
Fabio Del Bello, Dario Ambrosini, Alessandro Bonifazi, Amy Hauck Newman, Thomas M Keck, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Loredana Cappellacci, Antonio Cilia, Silvia Franchini, Wilma Quaglia
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia. ACS chemical neuroscience 10 (5) (2019)

Gianfabio Giorgioni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gianfabio Giorgioni